NIH-funded research Sbir 2 grant

High-Speed, Automated Analysis of Tiny Microplastics

Official title: High-Speed Automated Analysis of Sub-20 µm Microplastics by Photothermal Infrared Spectroscopy

Funded at Photothermal Spectroscopy Corp. · NIH-11312399 · Data updated 2026-11-12

A new automated system to quickly detect and identify tiny microplastics (smaller than 20 micrometers) in air, water, soil, and food to help protect health and the environment.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionPhotothermal Spectroscopy Corp.
NIH-funded
Lab location1 site (Santa Barbara, United States)
Project startAugust 13, 2026
Project endJuly 31, 2028
Funding year2026
Award (this year)$1,022,908
NIH project number1R44ES035665-01A1
Project IDNIH-11312399 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable (environmental health focus; no human participation required).

Less likely to help

No direct patient involvement or clinical application in this grant.

What this research studies

This project aims to develop the Photothermal Infrared Particle Analyzer (PIPA), a fast, automated platform that can image and chemically identify more than 1,000 microplastic particles per hour with sub-micron resolution. It uses innovative laser-scanning photothermal infrared microscopy to overcome current limits of FT-IR and Raman methods, enabling high-throughput analysis. The system will automatically segment particles, pre-screen to remove non-plastics, and apply advanced classification to report size, shape, and composition. The goal is to provide rapid, reliable data to researchers, regulators, and industry to better understand exposure and risks from microplastics.

Why it matters

Potential benefit: If successful, the platform could dramatically accelerate and streamline microplastic monitoring, informing safer products and environmental policies.

How similar studies have gone: Current methods are slower and less capable at sub-20 µm scale; this work aims to dramatically improve throughput and resolution, with some prior photothermal techniques informing the approach.

Where this research is happening

  • Photothermal Spectroscopy Corp.
    Santa Barbara, United States
    Active

Researchers

  • Principal investigator: Kjoller, Kevin — Photothermal Spectroscopy Corp.
  • Study coordinator: Kjoller, Kevin

Related research

Other NIH-funded projects on the same topics.

  • High-speed, label-free chemical imaging for live cells in multiwell plates

    A next-generation PT-SRS microscope will let scientists image live cells in standard 96-well plates quickly and without labels.

    NIH research Photothermal Spectroscopy Corp. · Santa Barbara, United States · NIH-11407011

  • Advanced Imaging for Alzheimer's Disease Research

    This project is creating a new, super-fast microscope to get a much clearer look at tiny details in tissues, especially for conditions like Alzheimer's disease.

    NIH research Photothermal Spectroscopy Corp. · Santa Barbara, United States · NIH-11131289

  • Advanced imaging technique for analyzing biological tissues

    This study is testing a new imaging technique that helps doctors see and understand the tiny details in brain tissues affected by conditions like Alzheimer's disease much faster and clearer, which could lead to better diagnoses and treatments for patients.

    NIH research Photothermal Spectroscopy Corp. · Santa Barbara, United States · NIH-10919106

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.